BHB has also been shown to inhibit glioma cell migration by inhibiting the NLRP3 inflammasome, suggesting that BHB may reduce the inflammatory microenvironment, providing an ancillary therapeutic benefit to the intervention of gliomas [192]. The gene discussed is NLRP3; the disease is central nervous system cancer.